Spyre Therapeutics, Inc. Stock Forecast
Green day on Wednesday for Spyre Therapeutics, Inc. stock after gaining 2.54%
(Updated on May 01, 2024)
The Spyre Therapeutics, Inc. stock price gained 2.54% on the last trading day (Wednesday, 1st May 2024), rising from $33.03 to $33.87. During the last trading day the stock fluctuated 9.57% from a day low at $31.39 to a day high of $34.39. The price has risen in 6 of the last 10 days but is still down by -1.28% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 179 thousand more shares were traded than the day before. In total, 669 thousand shares were bought and sold for approximately $22.64 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.27% during the next 3 months and, with a 90% probability hold a price between $25.89 and $32.99 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
SYRE Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 4.50%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Spyre Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $37.00. On a fall, the stock will find some support from the short-term average at $33.58. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Spyre Therapeutics, Inc. stock
Spyre Therapeutics, Inc. finds support from accumulated volume at $33.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.01 between high and low, or 9.57%. For the last week, the stock has had daily average volatility of 8.16%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (SYRE) For The Upcoming Trading Day Of Thursday 2nd
For the upcoming trading day on Thursday, 2nd we expect Spyre Therapeutics, Inc. to open at $33.22, and during the day (based on 14 day Average True Range), to move between $30.85 and $36.89, which gives a possible trading interval of +/-$3.02 (+/-8.93%) up or down from last closing price. If Spyre Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 17.85% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $33.30 (1.70%) than the resistance at $34.97 (3.25%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Spyre Therapeutics, Inc. will release earnings BMO on Thursday, May 09, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.90. We will update the financials statements for Spyre Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 0% in the first trading day after earnings release.
Is Spyre Therapeutics, Inc. stock A Buy?
Spyre Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -1.171 Sell Candidate Unchanged
Predicted Opening Price for Spyre Therapeutics, Inc. of Thursday, May 2, 2024
| Fair opening price May 2, 2024 | Current price |
|---|---|
| $33.22 ( 1.93%) | $33.87 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for SYRE
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 36.22 | 6.94 % | |
| R2 | 35.07 | 3.55 % | ||
| R1 | 34.36 | 1.46 % | ||
| Current price: | 33.87 | |||
| Support | S1 | 32.07 | -5.32 % | |
| S2 | 31.36 | -7.42 % | ||
| S3 | 30.21 | -10.81 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 37.93 | 11.99 % | |
| R2 | 37.65 | 11.16 % | ||
| R1 | 34.97 | 3.25 % | ||
| Current price | 33.87 | |||
| Support | S1 | 33.30 | -1.70% | |
| S2 | 33.03 | -2.48% | ||
| S3 | 32.41 | -4.31% |
FAQ
Click here for our free guide on how to buy Spyre Therapeutics, Inc. Stock.
